Danaher Corporation $DHR Shares Newly Purchased by Finer Wealth Management Inc.

Finer Wealth Management Inc. purchased a new stake in Danaher Corporation (NYSE:DHR) in the 3rd quarter, Holdings Channel reports. The firm purchased 2,781 shares of the conglomerate’s stock, valued at approximately $616,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Marquette Asset Management LLC lifted its holdings in shares of Danaher by 192.1% during the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 73 shares during the period. N.E.W. Advisory Services LLC acquired a new stake in shares of Danaher in the second quarter worth approximately $25,000. Main Street Group LTD purchased a new stake in Danaher in the first quarter valued at approximately $25,000. Field & Main Bank purchased a new stake in Danaher in the second quarter valued at approximately $29,000. Finally, Evolution Wealth Management Inc. grew its holdings in Danaher by 208.0% in the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 104 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on DHR shares. Stifel Nicolaus dropped their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Morgan Stanley increased their price target on shares of Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a research note on Monday, October 12th. Evercore reiterated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. The Goldman Sachs Group boosted their price objective on shares of Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Finally, Wells Fargo & Company lowered their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. Two research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $235.41.

Danaher Stock Performance

Danaher stock opened at $228.87 on Friday. The stock’s 50-day moving average is $214.04 and its 200-day moving average is $195.97. The company has a market cap of $160.89 billion, a price-to-earnings ratio of 40.65, a price-to-earnings-growth ratio of 2.88 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the previous year, the company posted $0.77 EPS. The company’s revenue was up 5.5% compared to the same quarter last year. Equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.40 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is presently 28.42%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.